Inventor
ROBERT DAVIS
Inventor
US
Overview
Patents· 65 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07DHeterocyclic compounds13%
A61BDiagnosis6%
C07BGeneral methods of organic chemistry4%
B82YSpecific uses or applications of nanostructures2%
G06FElectric digital data processing2%
A47KSanitary equipment1%
B62DMotor vehicles1%
C01BNon-metallic elements1%
PatentTitleYear
12,565,499Compounds and methods202612,533,355Methods of treatment comprising administering lumateperone mono-tosylate capsules202612,513,119Virtual personal mailbox system and method202512,496,300Methods of treating acute depression and anxiety202512,486,569Infiltrated carbon nanotubes202512,470,780Supplemental content placement optimizer202512,465,570Methods202512,441,413Reinforcing element for reinforcing a structural element202512,440,489Organic compounds202512,410,175Compounds202512,409,176Methods of treating acute depression202512,396,992Organic compounds202512,397,691Outdoor power equipment with converter seated and standing operator positions202512,376,333Configurable low ohmic power circuits202512,364,694Organic compounds202512,336,989Transmucosal methods for treating psychiatric and neurological conditions202512,325,726Organic compounds202512,310,463Quick-release swivel latches202512,304,763Sheet material dispense and cutting systems and methods of use202512,268,686Transmucosal methods for treating psychiatric and neurological conditions202512,272,109Method and system for automated debris detection202512,269,825Organic compounds202512,264,160Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one for treating central nervous system disorders202512,240,850Pharmaceutical compositions comprising 4-((6bR, 10aS)-3-methyl-2,3,6b,9,10, 10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-ol for treating central nervous system disorders202512,195,463Organic compounds202512,195,462Organic compound202512,173,004Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugs202412,144,808Compositions and methods202412,128,043Pharmaceutical capsules comprising lumateperone mono-tosylate202412,090,155Methods202412,070,459Pharmaceutical capsule compositions comprising lumateperone mono-tosylate202412,023,331Methods202412,004,582Easy-lace strap component and strap component system202411,980,617Methods of treating acute depression and/or acute anxiety202411,957,791Methods202411,958,852Compounds and methods202411,895,781Miniaturized impedance sensors202411,885,011Infiltrating carbon nanotubes with carbon to prevent delamination from a substrate202411,883,146Methods and devices for selecting miniaturized impedance electrodes of miniaturized impedance sensors202411,883,199Interdigitated impedance electrodes of miniaturized impedance sensors202411,877,845Miniaturized spectrometers on transparent substrates202411,844,757Organic compounds202311,839,614Methods for treating or mitigating cardiotoxicity characterized by inhibition of adenosine A202311,806,348Methods of treatment using pharmaceutical capsule compositions comprising lumateperone mono-tosylate202311,806,347Transmucosal methods for treating psychiatric and neurological conditions202311,771,334Methods and devices for aligning miniaturized impedance sensors in wearable devices202311,773,579Washing toilet seat202311,773,095Organic compounds202311,759,465Uses202311,701,023Miniaturized impedance sensors for wearable devices202311,690,842Pharmaceutical capsule compositions comprising lumateperone mono-tosylate202311,680,065Pharmaceutical compositions comprising 4-(6Br,10aS)-3-methyl-2, 3, 6b, 9, 10, 10a-hexahydro-1H, 7H-pyrido[3', 4', 5] pyrolo[1,2,3-de] quinoxalin-8YL)-1-(4-fluorophenyl)-butane-1-one and methods of treating conditions of the central nervous system202311,630,316Miniaturized collimators202311,612,604Methods of treating cancer with PLK4 inhibitors202311,589,764Methods and devices for aligning miniaturized spectrometers and impedance sensors in wearable devices202311,560,382Organic compounds202311,471,078Miniaturized spectrometers for wearable devices202211,464,781PDE1 inhibitors for ophthalmic disorders202211,427,587Organic compounds202211,421,411Washing toilet seat202211,376,249Organic compounds202211,367,265Method and system for automated debris detection202211,358,770Contact lens blister pack label and method for adjoining blister packs202211,284,809Impedance sensors for detecting heart wave forms202211,202,771Hemp powder2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Based in US· patent location history
2022–2026Patents assigned to INTRA CELLULAR THERAPIES INC (38)· patent assignee history
2022–2025Patents assigned to UNIV BRIGHAM YOUNG (12)· patent assignee history
2022–2023Patents assigned to BEMIS MFG CO (2)· patent assignee history
2022Based in GB· patent location history
2024–2025Patents assigned to TULA HEALTH INC (3)· patent assignee history
2024–2025Patents assigned to ASPETTO INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INTRA CELLULAR THERAPIES INC | 38 | 2022–2026 |
| UNIV BRIGHAM YOUNG | 12 | 2022–2025 |
| TULA HEALTH INC | 3 | 2024–2025 |
| ASPETTO INC | 2 | 2024–2025 |
| BEMIS MFG CO | 2 | 2022–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 64 | 2021–2026 |
| GB | 1 | 2022 |